These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15130596)

  • 1. Effect of chlorpyrifos on efflux transporter gene expression and function in Caco-2 cells.
    Agarwala S; Chen W; Cook TJ
    Toxicol In Vitro; 2004 Aug; 18(4):403-9. PubMed ID: 15130596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive toxicity of the organophosphorus insecticides chlorpyrifos and methyl parathion in adult rats.
    Karanth S; Liu J; Olivier K; Pope C
    Toxicol Appl Pharmacol; 2004 Apr; 196(2):183-90. PubMed ID: 15081265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of continuous exposure to digoxin on MDR1 function and expression in Caco-2 cells.
    Takara K; Tsujimoto M; Ohnishi N; Yokoyama T
    J Pharm Pharmacol; 2003 May; 55(5):675-81. PubMed ID: 12831511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines.
    Siissalo S; Laitinen L; Koljonen M; Vellonen KS; Kortejärvi H; Urtti A; Hirvonen J; Kaukonen AM
    Eur J Pharm Biopharm; 2007 Sep; 67(2):548-54. PubMed ID: 17475454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of extension outgrowth in differentiating rat C6 glioma cells by chlorpyrifos and chlorpyrifos oxon: effects on microtubule proteins.
    Sachana M; Flaskos J; Sidiropoulou E; Yavari CA; Hargreaves AJ
    Toxicol In Vitro; 2008 Aug; 22(5):1387-91. PubMed ID: 18417317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Th1/Th2 cytokines in human blood after in vitro treatment with chlorpyrifos, and its metabolites, in combination with endotoxin LPS and allergen Der p1.
    Duramad P; Tager IB; Leikauf J; Eskenazi B; Holland NT
    J Appl Toxicol; 2006; 26(5):458-65. PubMed ID: 16871525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes.
    Parran DK; Magnin G; Li W; Jortner BS; Ehrich M
    Neurotoxicology; 2005 Jan; 26(1):77-88. PubMed ID: 15527875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorpyrifos exposure causes alternation in dopamine metabolism in PC12 cells.
    Xu F; Chang X; Lou D; Wu Q; Zhou Z
    Toxicol Mech Methods; 2012 May; 22(4):309-14. PubMed ID: 22356570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorpyrifos and its metabolites alter gene expression at non-cytotoxic concentrations in D3 mouse embryonic stem cells under in vitro differentiation: considerations for embryotoxic risk assessment.
    Estevan C; Vilanova E; Sogorb MA
    Toxicol Lett; 2013 Feb; 217(1):14-22. PubMed ID: 23220036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.
    Hayeshi R; Hilgendorf C; Artursson P; Augustijns P; Brodin B; Dehertogh P; Fisher K; Fossati L; Hovenkamp E; Korjamo T; Masungi C; Maubon N; Mols R; Müllertz A; Mönkkönen J; O'Driscoll C; Oppers-Tiemissen HM; Ragnarsson EG; Rooseboom M; Ungell AL
    Eur J Pharm Sci; 2008 Dec; 35(5):383-96. PubMed ID: 18782614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient alterations of the blood-brain barrier tight junction and receptor potential channel gene expression by chlorpyrifos.
    Li W; Ehrich M
    J Appl Toxicol; 2013 Oct; 33(10):1187-91. PubMed ID: 22611033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells.
    Celius T; Garberg P; Lundgren B
    Biochem Biophys Res Commun; 2004 Nov; 324(1):365-71. PubMed ID: 15465028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent pharmacokinetic and pharmacodynamic response in preweanling rats following oral exposure to the organophosphorus insecticide chlorpyrifos.
    Timchalk C; Poet TS; Kousba AA
    Toxicology; 2006 Mar; 220(1):13-25. PubMed ID: 16343727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
    Wang XD; Meng MX; Gao LB; Liu T; Xu Q; Zeng S
    Int J Pharm; 2009 Aug; 378(1-2):1-8. PubMed ID: 19465099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity of chlorpyrifos and its oxon derivatives to soil microbial activity by combined methods.
    Wang F; Yao J; Chen H; Chen K; Trebse P; Zaray G
    Chemosphere; 2010 Jan; 78(3):319-26. PubMed ID: 19900695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative chlorpyrifos pharmacokinetics via multiple routes of exposure and vehicles of administration in the adult rat.
    Smith JN; Campbell JA; Busby-Hjerpe AL; Lee S; Poet TS; Barr DB; Timchalk C
    Toxicology; 2009 Jun; 261(1-2):47-58. PubMed ID: 19397948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective regulation of MDR1 expression in Caco-2 cells by cetirizine enantiomers.
    Shen S; He Y; Zeng S
    Chirality; 2007 Jun; 19(6):485-90. PubMed ID: 17394131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotine exposure on in vitro metabolism of chlorpyrifos in male Sprague-Dawley rats.
    Lee S; Busby AL; Timchalk C; Poet TS
    J Toxicol Environ Health A; 2009; 72(2):74-82. PubMed ID: 19034796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective downregulation of the MDR1 gene product in Caco-2 cells by stable transfection to prove its relevance in secretory drug transport.
    Hilgendorf C; Spahn-Langguth H; Rhedin M; Regårdh CG; Löwenadler B; Langguth P
    Mol Pharm; 2005; 2(1):64-73. PubMed ID: 15804179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.